Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C16H21NO3.ClH |
| Molecular Weight | 311.804 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)C3=CC=CC=C3
InChI
InChIKey=FRMDDIJBLQNNTC-RDYJJYPNSA-N
InChI=1S/C16H21NO3.ClH/c1-17-12-7-8-13(17)10-14(9-12)20-16(19)15(18)11-5-3-2-4-6-11;/h2-6,12-15,18H,7-10H2,1H3;1H/t12-,13+,14+,15?;
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Approved UseHydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough. Launch Date1983 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Anticholinergic delirium caused by topical homatropine ophthalmologic solution: confirmation by anticholinergic radioreceptor assay in two cases. | 1992 Spring |
|
| Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. | 1995 Mar |
|
| Tubulointerstitial nephritis and uveitis syndrome. | 2003 Apr |
|
| Microbial keratitis and vision loss with contact lenses. | 2003 Jan |
|
| Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. | 2003 Jan |
|
| Human carboxylesterase 1: from drug metabolism to drug discovery. | 2003 Jun |
|
| Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. | 2003 May |
|
| Familial HLA-A2- and HLA-B7-associated anterior uveitis. | 2004 Oct |
|
| Acute posterior multifocal placoid pigment epitheliopathy after meningococcal C conjugate vaccine. | 2005 Apr |
|
| Intramuscular ophthalmic homatropine vs. atropine to prevent lethality in rates with dichlorvos poisoning. | 2006 Dec |
|
| Homatropine and psychosis in Weill-Marchesani syndrome. | 2006 Jul |
|
| Efficacy of trypan blue in posterior capsulorhexis with optic capture in pediatric cataracts [ISRCTN48221688]. | 2006 Mar 16 |
|
| [Neurotoxic effects induced by the topical administration of cycloplegics. A case report and review of the literature]. | 2006 Nov 16-30 |
|
| Role of the medial prefrontal cortex in cardiovascular responses to acute restraint in rats. | 2006 Nov 17 |
|
| Pretreating rats with parenteral ophthalmic antimuscarinic agents decreases mortality from lethal organophosphate poisoning. | 2007 Apr |
|
| Enantioseparation of chiral tropa alkaloids by means of cyclodextrin-modified microemulsion electrokinetic chromatography. | 2007 Aug |
|
| Increasing the scale of true moving bed electrophoretic separations using filtration to reduce solvent volumetric flows between sections II and III. | 2007 Jan 5 |
|
| True moving bed electrophoresis using stepped electric field gradients. | 2007 May |
|
| Capillary electrophoresis of tropane alkaloids and glycoalkaloids occurring in Solanaceae plants. | 2008 |
|
| Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project. | 2010 |
|
| Tubulointerstitial nephritis with uveitis syndrome: A case report and review of literature. | 2010 Apr |
|
| Is homatropine 5% effective in reducing pain associated with corneal abrasion when compared with placebo? A randomized controlled trial. | 2010 Dec |
|
| Current approach in the diagnosis and management of panuveitis. | 2010 Jan-Feb |
|
| The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. | 2010 Mar |
|
| Acute postoperative endophthalmitis by Gemella haemolysans. | 2010 May-Jun |
|
| Refractive error and visual functions in children with special needs compared with the first grade school students in oman. | 2010 Oct |
|
| Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy. | 2010 Sep |
|
| Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
|
| Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats. | 2012 Apr |
Sample Use Guides
Adults and Adolescents 12 Years of Age and Older: 1 tablet or 5 mL (1 teaspoonful) of the oral solution every 4 to 6 hours as needed; do not exceed 6 tablets or 30 mL (6 teaspoonfuls) in 24 hours. Children 6 to 11 Years of Age: 1/2 tablet or 2.5 mL (1/2 teaspoonful) of the oral solution every 4 to 6 hours as needed; do not exceed 3 tablets or 15 mL (3 teaspoonfuls) in 24 hours.
Route of Administration:
Oral
Isolated caprine urinary bladder detrusor muscle strips were incubated with homatropine at 5 uM after being contracted with 100 mum acetylcholine. The drug inhibited the ACh-induced contraction of the caprine detrusor and that this inhibition was reversed by raising the concentration of ACh.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000086686
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY | |||
|
211-280-0
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY | |||
|
637-21-8
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY | |||
|
SUB02531MIG
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY | |||
|
m6038
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID10858796
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY | |||
|
365MO3S3N9
Created by
admin on Fri Dec 15 17:34:13 GMT 2023 , Edited by admin on Fri Dec 15 17:34:13 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
